Diphtheria + Tetanus + Pertussis + Poliomyelitis vaccine

ArticlesRefrigerated StorageLactation Safety Information ·


Refrigerated Storage


Suspension for injection in pre-filled syringe

In the event of an inadvertent temperature excursion the following data may be used:
A maximum cumulative time of 72 hours is permitted for the vaccine to be at temperatures above 8°C through to 25°C.
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk
Contact GSK in cases where the product has been exposed to temperature deviation other than described above. Refer to the current BNF for company contact details.

No, if exposed to temperatures described above
Yes, if exposed to temperatures described above

Do not freeze.
Store in the original package in order to protect from light.

19 December 2019
London Medicines Information Service

RepevaxSanofi Pasteur

Sanofi Pasteur

Contact Sanofi Pasteur in all cases where a deviation from the recommended storage conditions has occurred. Refer to the current BNF for company contact details.

21 October 2020
London MI Service

Lactation Safety Information

In adults, used only to boost immunity in pregnant women – use during breastfeeding therefore unlikely. Available as combination inactivated vaccine - low dose diphtheria/tetanus/acellular pertussis/inactivated polio vaccine (dTaP/IPV)
16 September 2020